informaworld logo
HOME . ABOUT US . CONTACT US 		HELP . PUBLISH WITH US . LIBRARIANS 
ebooks logo journals logo reference works logo abstract databases logo
bullet  SIGN IN Register | Why Register? | Got a Voucher? alerts   marked lists   shopping cart 

informaworld

HOME   |   SEARCH   |   BROWSE
    Issues List       Latest Issue       Volume 19 Issue 3       Aims & Scope       Editorial Board       Instructions for Authors       Subscribe      
<< earliestearliest   < prevprev   Issue listissues   next >next   latest >>latest
Publisher Logo Publication Cover
Search within this journal
iOpen

Journal of Biopharmaceutical Statistics, Volume 19 Issue 3 2009

Now Listed with IF of 0.951 ©2009 Thomson Reuters, 2008 Journal Citiation Reports®
ISSN: 1520-5711 (electronic) 1054-3406 (paper)
Publication Frequency: 6 issues per year
select-down Click for help
Editorials
Editorial: From the Editors
Terry Hyslop; Sin-Ho Jung
Page 413
Abstract | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Original Articles
Theoretical and Practical Application of Traditional and Accelerated Titration Phase I Clinical Trial Designs: The Wayne State University Experience
Elisabeth I. Heath;  Patricia M. LoRusso;  S. Percy Ivy;  Larry Rubinstein;  Michaele C. Christian; Lance K. Heilbrun
Pages 414 – 423
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Optimal Cost-Effective Designs of Phase II Proof of Concept Trials and Associated Go–No Go Decisions
Cong Chen; Robert A. Beckman*
Pages 424 – 436
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Continual Reassessment Method vs. Traditional Empirically Based Design: Modifications Motivated by Phase I Trials in Pediatric Oncology by the Pediatric Brain Tumor Consortium
Arzu Onar;  Mehmet Kocak; James M. Boyett
Pages 437 – 455
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Between-Arm Comparisons in Randomized Phase II Trials
Sin-Ho Jung; Stephen L. George
Pages 456 – 468
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
A Bayesian Case Study in Oncology Phase I Combination Dose-Finding Using Logistic Regression with Covariates
Stuart Bailey;  Beat Neuenschwander;  Glen Laird; Michael Branson
Pages 469 – 484
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Optimal Two-Stage Randomized Multinomial Designs for Phase II Oncology Trials
Linda Z. Sun;  Cong Chen; Kamlesh Patel
Pages 485 – 493
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Selecting Promising Treatments in Randomized Phase II Cancer Trials with an Active Control
Ying Kuen Cheung
Pages 494 – 508
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Design Issues in Dose-Finding Phase I Trials for Combinations of Two Agents
Shenghua Kelly Fan;  Alan P. Venook; Ying Lu
Pages 509 – 523
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Design of Phase II Cancer Trials for Evaluation of Cytostatic/Cytotoxic Agents
Masha Kocherginsky;  Ezra E. W. Cohen; Theodore Karrison
Pages 524 – 529
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Clinical Trial Designs for Predictive Biomarker Validation: One Size Does Not Fit All
Sumithra J. Mandrekar; Daniel J. Sargent
Pages 530 – 542
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Some Notable Properties of the Standard Oncology Phase I Design
Gregory J. Hather; Howard Mackey
Pages 543 – 555
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Current Issues in Oncology Drug Development, with a Focus on Phase II Trials
Daniel J. Sargent; Jeremy M. G. Taylor
Pages 556 – 562
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Book Reviews
A Review of: “Missing Data in Longitudinal Studies: Strategies for Bayesian Modeling and Sensitivity Analysis, by M. J. Daniels and J. W. Hogan”
Boca Raton: Chapman & Hall/CRC, 2008, ISBN 1-58488-609-9, xx + 303 pp., $79.95.
David Ohlssen
Pages 563 – 565
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
A Review of: “Validating Clinical Trial Data Reporting with SAS, by C. I. Matthews and B. C. Shilling”
Cary, NC: SAS Institute Inc., 2008, ISBN 978-1-59994-128-8, xii + 206 pp., $36.95.
Neepa Ray
Pages 566 – 567
Abstract | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
A Review of: “An Introduction to Generalized Linear Models, Third Edition, by A. J. Dobson and A. G. Barnett”
Boca Raton: Chapman & Hall/CRC, 2008, ISBN 978-1-58488-950-2, 307 pp., $59.95.
Erica E. M. Moodie
Pages 568 – 569
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
select-up

Privacy Policy | Terms & Conditions | Accessibility | RSS
FAQs in: English . Français . Español . 中文（简体和繁體）
© 2009 Informa plc